// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Prognostic implications of baseline and change from baseline values of plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure

J. Rouleau - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Improving the Appropriate Use of Transthoracic Echocardiography- The results of the Echo WISELY trial

A. Johri - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Use of drug eluting stents compared to bare metal stents in ST segment elevation myocardial infarction is associated with reduced mortality and cardiovascular outcomes: results from the TOTAL trial

G. Stankovic - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Effect of cardiac rehabilitation dose on mortality and morbidity: how low can we go - a systematic review and meta-regression

C. Santiago De Araujo Pio - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry

M. Proietti - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

H.W. Farber - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

INO

Steroids in cardiac surgery (SIRS): infection substudy

G.R. McClure - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Polypharmacy: A reality in ST-elevation myocardial infarction

J. Shavadia - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury

I. Bil-Lula - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Nitric oxide

The PROTROPICS feasibility: prognostic value of elevated troponins in critical illness

N. Savija - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

GW29-e0697 Long-Term Outcomes of Surgical Aortic Valve Replacement in Chronic Dialysis Patients

Defen Peng - Great Wall International Congress of Cardiology (GWICC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of Oropharyngeal Leak Pressure Between the Ambu AuraGain and the LMA Supreme: A Randomized Controlled Trial

David T. Wong - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Lidocaine

Universal Definition of Perioperative Bleeding (UDPB) in Cardiac Surgery: Validation of a Clinical Trial Endpoint

Justyna Bartoszko - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Effect of Intranasal Insulin Administration on Glycemia in Patients Undergoing Cardiac Surgery

Yosuke Nakadate - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Neuropeptides

Choice of Intraoperative Resuscitation Fluid in Coronary Bypass Surgery: A Cost Effectiveness Analysis

Lavarnan Sivanathan - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Serum Albumin and Its Synthesis in Surgical Patients

Keisuke Nakazawa - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Fibrinogen (IV)

Cinaciguat Confers a Survival Advantage in Sepsis in Young and Aged Mice

Kimberly Macala - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Norepinephrine bitartrate

Wireless Respiratory Monitoring After Surgery: A RCT

James E. Paul - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Naloxone

Developing a Novel ANTS Assessment Curriculum

Richa Sharma - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Beyond Masks and Syringes: Early Ideas of Anesthesiology in Canada

Richa Sharma - American Society of Anesthesiologists (ASA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved